BioArctic AB (publ) (BRCTF)
USD 15.67
(0.0%)
USD 15.67
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.18 Billion SEK | 38.19% |
| 2022 | 858.3 Million SEK | -4.39% |
| 2021 | 897.73 Million SEK | -14.53% |
| 2020 | 1.05 Billion SEK | -11.24% |
| 2019 | 1.18 Billion SEK | -15.05% |
| 2018 | 1.39 Billion SEK | 22.14% |
| 2017 | 1.14 Billion SEK | 61.09% |
| 2016 | 707.97 Million SEK | 439.98% |
| 2015 | 131.11 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.13 Billion SEK | -0.38% |
| 2024 Q1 | 1.13 Billion SEK | -4.19% |
| 2023 Q3 | 1.24 Billion SEK | 14.33% |
| 2023 Q1 | 1.15 Billion SEK | 34.56% |
| 2023 FY | 1.18 Billion SEK | 38.19% |
| 2023 Q2 | 1.08 Billion SEK | -5.92% |
| 2023 Q4 | 1.18 Billion SEK | -4.52% |
| 2022 Q1 | 846.8 Million SEK | -5.67% |
| 2022 Q4 | 858.3 Million SEK | -5.22% |
| 2022 Q2 | 794.58 Million SEK | -6.17% |
| 2022 FY | 858.3 Million SEK | -4.39% |
| 2022 Q3 | 905.57 Million SEK | 13.97% |
| 2021 FY | 897.73 Million SEK | -14.53% |
| 2021 Q4 | 897.73 Million SEK | -4.01% |
| 2021 Q3 | 935.22 Million SEK | -3.93% |
| 2021 Q2 | 973.48 Million SEK | -3.23% |
| 2021 Q1 | 1 Billion SEK | -4.22% |
| 2020 Q2 | 1.09 Billion SEK | -3.74% |
| 2020 Q3 | 1.07 Billion SEK | -2.16% |
| 2020 Q4 | 1.05 Billion SEK | -2.4% |
| 2020 FY | 1.05 Billion SEK | -11.24% |
| 2020 Q1 | 1.14 Billion SEK | -3.45% |
| 2019 Q4 | 1.18 Billion SEK | -4.54% |
| 2019 Q2 | 1.27 Billion SEK | -2.98% |
| 2019 Q1 | 1.31 Billion SEK | -5.64% |
| 2019 Q3 | 1.23 Billion SEK | -2.8% |
| 2019 FY | 1.18 Billion SEK | -15.05% |
| 2018 FY | 1.39 Billion SEK | 22.14% |
| 2018 Q4 | 1.39 Billion SEK | 34.95% |
| 2018 Q2 | 1.06 Billion SEK | -4.05% |
| 2018 Q1 | 1.1 Billion SEK | -2.79% |
| 2018 Q3 | 1.03 Billion SEK | -2.96% |
| 2017 FY | 1.14 Billion SEK | 61.09% |
| 2017 Q1 | - SEK | -100.0% |
| 2017 Q2 | 638.79 Million SEK | 0.0% |
| 2017 Q3 | 610.92 Million SEK | -4.36% |
| 2017 Q4 | 1.14 Billion SEK | 86.68% |
| 2016 FY | 707.97 Million SEK | 439.98% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q4 | 707.97 Million SEK | 0.0% |
| 2015 FY | 131.11 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -2953.204% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -16328.215% |
| SQZ Biotechnologies Company | 107.18 Million USD | -1006.55% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -11138.185% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -810.891% |
| Mesoblast Limited | 667.9 Million USD | -77.583% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1638921.626% |
| Genus plc | 1.02 Billion USD | -15.276% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -87217.362% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -237572.406% |
| Marizyme, Inc. | 22.01 Million USD | -5287.572% |
| ContraFect Corporation | 20.67 Million USD | -5635.664% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -189067.145% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -303737.424% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -310247.823% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -82724.825% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -28507.615% |
| MultiCell Technologies, Inc. | 126.22 USD | -939690915.687% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -126120.271% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -822.946% |
| EV Biologics, Inc. | 431.71 Thousand USD | -274636.979% |
| Q BioMed Inc. | 3.51 Million USD | -33638.366% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -3271.551% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -153807.381% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -453854.232% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1606638.103% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -156.253% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -3851.624% |
| Skye Bioscience, Inc. | 11.94 Million USD | -9833.31% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -35700.595% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -43087.666% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -60470.149% |
| IMV Inc. | 31.33 Million USD | -3685.301% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -172423.95% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -45462.378% |
| GB Sciences, Inc. | 103.44 Thousand USD | -1146511.628% |
| Alpha Cognition Inc. | 2.45 Million USD | -48268.506% |
| HST Global, Inc. | 1526.00 USD | -77724539.581% |
| CSL Limited | 38.02 Billion USD | 96.881% |
| Halberd Corporation | 10.13 Thousand USD | -11707312.891% |
| Enzolytics Inc. | 361.7 Million USD | -227.912% |
| Resverlogix Corp. | 8.11 Million USD | -14515.872% |
| Affymax, Inc. | 7.44 Million USD | -15835.483% |
| SYBLEU INC | 330.46 Thousand USD | -358808.578% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -63060.479% |
| argenx SE | 4.54 Billion USD | 73.889% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -4144.482% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -2386.432% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -5206335.187% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -13153.519% |
| AVAX Technologies, Inc. | 7.37 Million USD | -15977.711% |
| Zenith Capital Corp. | 7410.00 USD | -16006350.742% |
| Genscript Biotech Corporation | 3.38 Billion USD | 64.975% |
| Ember Therapeutics, Inc. | 184.00 USD | -644607508.696% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -368469.262% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -453703.125% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -165.753% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -81763.804% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -39108.075% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -2150.58% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -127715.501% |
| BioStem Technologies, Inc. | 14.56 Million USD | -8045.977% |
| ONE Bio Corp. | 70.08 Million USD | -1592.33% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -2077312.688% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -51345267.965% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -119952.39% |
| Agentix Corp. | 261.39 Thousand USD | -453654.514% |
| LadRx Corporation | 2.3 Million USD | -51292.489% |
| Cell Source, Inc. | 195.17 Thousand USD | -607612.211% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -246713.177% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -335313.173% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -335313.173% |
| NovAccess Global Inc. | 62.24 Thousand USD | -1905307.403% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -185324.353% |
| Itoco Inc. | 1.4 Million USD | -84615.5% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -1239828.076% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -1118841.509% |
| Kadimastem Ltd | 2.3 Million USD | -51377.292% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1553293.404% |
| CytoDyn Inc. | 11.13 Million USD | -10550.844% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -829487.612% |
| Mobile Lads Corp. | 52.00 USD | -2280919130.769% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -6633445.861% |
| Qrons Inc. | 420.00 USD | -282399423.81% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -307595.78% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -214722.502% |
| Rebus Holdings, Inc. | 5000.00 USD | -23721460.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -289595.717% |
| International Stem Cell Corporation | 5.39 Million USD | -21905.158% |
| Bioxytran, Inc. | 137.63 Thousand USD | -861637.311% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -7806.222% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -7054.099% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -1501264.557% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -137070.065% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -15678.608% |
| Neutra Corp. | 2851.00 USD | -41602074.676% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -3560.057% |
| PureTech Health plc | 693.97 Million USD | -70.911% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -14595.39% |
| IXICO plc | 15.84 Million USD | -7386.022% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -14221.154% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -1047.921% |
| CSL Limited | 38.02 Billion USD | 96.881% |
| Cellectis S.A. | 333.99 Million USD | -255.119% |